|
Sign In to gain access to subscriptions and/or personal tools.
|
Cardio-diabetes: new ESC-EASD joint guidelines
Caroline Day
Diabetes Research Group, School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK, cday{at}mededuk.com
References
- The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summary. Eur Heart J 2007;28:88-136.[Free Full Text]
- The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes and cardiovascular diseases: full text. www.escardio.organdwww.easd.org (Accessed April 2007).
- De Backer G., Ambrosiomi E., Borch-Johnsen K., et al. Third joint task force of the European and other societies. European Guidelines on Cardiovascular Disease Prevention. Eur J Cardiovasc Preven Rehab 2003; 10(suppl1):S1-S78.
- Qiao Q., Jousilahti P., Eriksson J., Tuomilehto J. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes at follow-up. Diabetes Care 2003;26:2910-14.[Abstract/Free Full Text]
- Matz K., Keresztes K., Tatschl C. et al. Disorders of glucose metabolism in acute stroke patients. An underrecognised problem. Diabetes Care 2006; 29:792-7.[Abstract/Free Full Text]
- The DECODE Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1998;317:371-75.[Abstract/Free Full Text]
- Vinik AI, Jenkins DJA. Dietary fiber in management of diabetes. Diabetes Care 1998;11:160-73.
- Mozaffarian D., Katan MB, Ascherio A. et al. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601-13.[Free Full Text]
- Zaloga GP, Harvey KA, Stillwell W., Siddiqui R. Trans fatty acids and coronary heart disease. Nutr Clin Pract 2006;21:505-12.[Abstract/Free Full Text]
- Sun Q., Ma J., Campos H. et al. A Prospective Study of Trans Fatty Acids in Erythrocytes and Risk of Coronary Heart Disease. Circulation 2007, March 26 (Epub ahead of print).
- Oomen CM, Ocke MC, Feskens EJ, et al. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 2001;357:746-51.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Stender S., Dyerberg J. The importance of trans-fatty acids for health. Update 2001. Ugeskr Laeger 2001;163:2349-53.[Medline]
[Order article via Infotrieve]
- New York City Department of Health and Mental Hygiene. Cardiovascular disease prevention. Healthy heart - avoid trans fats. December 5th 2006. http://www.nyc.gov/html/doh/html/cardio/cardiotransfat.shtml (Accessed April 2007).
- Food Standards Agency. FSA Nutrient and food based guidelines for UK institutions. October 2006. http://www.food.gov.uk/multimedia/pdfs/nutguideuk.pdf#page=3, (Accessed April 2007).
- Jebb S., Steer T., Holmes C. The `Healthy Living social marketing initiative: A review of the evidence. An independent report commissioned by the Dept of Health. March 2007. http://www.mrc-hnr.cam.ac.uk/downloads/HNR_DH_HealthyLivingReport.pdf (Accessed April 2007).
- Buse JB, Ginsberg HN, Bakris GL et al. Primary prevention of cardiovascular disease in people with diabetes mellitus. A scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007;115:114-126 and Diabetes Care 2007;30:162-72.[Abstract/Free Full Text]
The British Journal of Diabetes & Vascular Disease, Vol. 7, No. 2,
47-48 (2007)
DOI: 10.1177/14746514070070020101

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|